CancerCare
In research, CancerCare stands highest in Medicine (#10,397 of 17,978 worldwide) and Health Sciences (#12,541 of 20,462 worldwide), over all time.
- World rank, 2022–2025
- #11,887 of 28,054 · #20,504 all time
- Rank in United States
- #1,619 of 4,192
- Research works
- 237 ▲ 40% vs 2013–17
- Citations
- 4.1k 17.3 per fractional work
- Top-10% rate
- 19.4% record average 16.5%
- Open access
- 31% world 28%
What is CancerCare known for in research?
The fields where it stands highest, over all time, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works |
|---|---|---|---|---|
| MedicineField | #10,397 of 17,978 | 15.9% | 140 | |
| Health SciencesDomain | #12,541 of 20,462 | 16.2% | 158 |
Each strip is that field’s whole ranked pool, with the notch where CancerCare sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 4.7×. Every wedge is a field page.
- Immunology and Microbiology 4.7×
- Economics, Econometrics and Finance 3.5×
- Medicine 3.3×
- Biochemistry, Genetics and Molecular Biology 2.0×
- Health Professions 1.9×
- Neuroscience 0.8×
- Psychology 0.4×
- Physics and Astronomy 0.3×
- Veterinary 0.3×
- Dentistry 0.3×
- Nursing 0.2×
- Social Sciences 0.2×
- Engineering 0.2×
- Pharmacology, Toxicology and Pharmaceutics 0.1×
- Decision Sciences 0.1×
- Computer Science 0.1×
- Arts and Humanities 0.0×
- Agricultural and Biological Sciences 0.0×
- Environmental Science 0.0×
Who are the top researchers at CancerCare?
Ranked on the composite score, Joyce N. Barlin lead among researchers whose main affiliation is CancerCare.
- 1 Joyce N. Barlin United States · #1,250,768 worldwide 8 citations · 18 works
Which keywords describe research at CancerCare?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Quality of Life, Chemotherapy, Health-related Quality of Life, Clinical Trials, Cancer Survivorship, Cost of Care, Financial Toxicity and Anxiety.
- Physician Communication
- Advance Care Planning
- Palliative Care
- Breast Cancer
- Healthcare Outcomes
- Ethical Considerations
- International Myeloma Working Group
- Diagnosis Criteria
- Proteasome Inhibitors
- Clinical Practice Guidelines
- Radiotherapy
- Immunity
- Prognostic Factors
- Psychosocial Interventions
- Patient-Reported Outcomes
- Inflammation
- Cost of Care
- Depression
- Clinical Trials
- Chemotherapy
- Quality of Life
- Health-related Quality of Life
- Cancer
- Cancer Survivorship
- Financial Toxicity
- Anxiety
- Physical Activity
- Tumor Microenvironment
- Metastasis
- Minimal Residual Disease
- Survival Analysis
- Immunotherapy
- Rituximab
- Immune Checkpoint Blockade
- PD-1 and PD-L1
- Targeted Therapy
- Training
- End-of-Life
- Patient-Centered Care
- Health Decision Aids
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Quality of Life5▲ 5.8×12 topics
- Chemotherapy4▲ 9.9×20 topics
- Health-related Quality of Life4▲ 27×3 topics
- Clinical Trials4▲ 8.3×8 topics
- Cancer3▲ 4.1×22 topics
- Depression3▲ 5.9×4 topics
- Cancer Survivorship3▲ 69×2 topics
- Cost of Care3▲ 166×1 topic
- Financial Toxicity3▲ 166×1 topic
- Inflammation3▲ 2.4×22 topics
- Anxiety3▲ 10×2 topics
- Patient-Reported Outcomes3▲ 91×1 topic
- Physical Activity3▲ 9.9×2 topics
- Psychosocial Interventions3▲ 91×1 topic
- Tumor Microenvironment3▲ 11×8 topics
- Prognostic Factors2▲ 9.2×9 topics
- Metastasis2▲ 11×8 topics
- Immunity2▲ 8.7×7 topics
- Minimal Residual Disease2▲ 49×2 topics
- Radiotherapy2▲ 8.9×10 topics
- Survival Analysis2▲ 13×6 topics
- Clinical Practice Guidelines2▲ 6.0×7 topics
- Immunotherapy2▲ 4.5×11 topics
- Proteasome Inhibitors2▲ 46×2 topics
- Rituximab2▲ 21×2 topics
- Diagnosis Criteria2▲ 89×1 topic
- Immune Checkpoint Blockade2▲ 28×1 topic
- International Myeloma Working Group2▲ 89×1 topic
- PD-1 and PD-L12▲ 28×1 topic
- Ethical Considerations2▲ 8.6×2 topics
- Targeted Therapy2▲ 13×5 topics
- Healthcare Outcomes2▲ 49×2 topics
- Training2▲ 12×2 topics
- Breast Cancer2▲ 11×8 topics
- End-of-Life2▲ 29×2 topics
- Palliative Care2▲ 16×2 topics
- Patient-Centered Care2▲ 34×2 topics
- Advance Care Planning2▲ 42×1 topic
- Health Decision Aids2▲ 94×1 topic
- Physician Communication2▲ 94×1 topic
Which research topics does CancerCare publish most on?
By volume in 2022–2025: Economic and Financial Impacts of Cancer, Cancer survivorship and care, Multiple Myeloma Research and Treatments and Cancer Immunotherapy and Biomarkers.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Economic and Financial Impacts of Cancer Economics and Econometrics 3 works
- 2 Cancer survivorship and care Oncology 3 works
- 3 Multiple Myeloma Research and Treatments Hematology 2 works
- 4 Cancer Immunotherapy and Biomarkers Oncology 2 works
- 5 Genetics, Bioinformatics, and Biomedical Research Molecular Biology 2 works
- 6 Patient-Provider Communication in Healthcare General Health Professions 2 works
- 7 Palliative Care and End-of-Life Issues Public Health, Environmental and Occupational Health 2 works
- 8 Chronic Lymphocytic Leukemia Research Genetics 2 works
- 9 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 1 works
- 10 Immunotherapy and Immune Responses Immunology 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has CancerCare's research output changed?
Output in 2018–2022 was 40% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in New York
- Columbia University
- New York University
- Icahn School of Medicine at Mount Sinai
- Memorial Sloan Kettering Cancer Center
- City University of New York
- Human Growth Foundation
- Columbia University Irving Medical Center
- Rockefeller University
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.